Skip to main content

Table 3 The improvement of bone mineral density for 1 year follow up

From: The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study

  

Immediate

Post-operation (g/cm2)

1-year follow-up

(g/cm2)

p-value

Group 1

(TPTD+DMAb)

Femoral neck

0.540 ± 0.12

0.546 ± 0.11

0.584

Total hip

0.654 ± 0.09

0.644 ± 0.11

0.152

Spine

0.735 ± 0.14

0.778 ± 0.13

< 0.001

Group 2

(DMAb)

Femoral neck

0.481 ± 0.11

0.467 ± 0.09

0.566

Total hip

0.626 ± 0.11

0.633 ± 0.11

0.454

Spine

0.702 ± 0.11

0.753 ± 0.78

0.002

  1. TPTD teriparatide, DMAb denosumab